The effects of intravenous (iv) administration of the opioid antagonis
ts naloxone and naltrexone on the restraint-induced suppression of the
pro-estrous LH surge were studied in cyclic female rats. To minimize
stress during repeated blood sampling, the rats were provided with a j
ugular vein cannula. Restraint stress for 6 hrs starting at t=-1 h (th
e onset of the LH surge being at t=O h) caused a suppression of LH lev
els (including peak height) during the period of the LH surge. Repeate
d naloxone injections, given 3 h (1 mg), 4 h (0.5 mg) and 5 h (0.5 mg)
after the onset of the LH surge, did not affect the restraint-induced
inhibition neither did pretreatment with 1 mg naloxone at t=-75 min (
i.e. 15 min before application of restraint). Naltrexone (2 mg) admini
stered at t=-15 min induced higher plasma LH levels at t=-6 min. When
rats were subsequently subjected to restraint for 5 hrs starting at t=
-5 min, the restraint-induced inhibition of surge levels of LH was not
affected. The results indicate that withdrawal of opioid activity in
cyclic female rats before the presumed onset of the LH surge results i
n a premature rise of LH levels. This is in accordance with the notion
that LH levels prior to the surge are under tonic inhibition of endog
enous opioid peptides (EOP). In addition, the data show that opioid re
ceptor antagonism during or before application of restraint does not a
lter the restraint-induced suppression of the LH surge. It is therefor
e concluded that EOP do not mediate the inhibitory effect of restraint
stress on the LH surge in cyclic rats.